Testing blood clotting in people with liver cirrhosis
Treatments studied
Part of Digestive system, Heart & circulation clinical trials.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis at University Hospital Vienna
- Your blood clotting tests are abnormal (INR above 1.5 and/or platelets below 50,000 per microliter)
- You are scheduled for one of these planned procedures: liver biopsy/needle, microwave or radiofrequency ablation, TIPS, or PTCD drain
- You can give informed consent (or have someone who can for you, if allowed by the study)
- You are age 18 or older
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to manage blood clotting around the time of a TIPS procedure in adults with cirrhosis, to see if a safer clotting strategy helps. It may be useful if you are having TIPS for a specific complication of liver disease.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
This early study tests whether the blood thinner pills rivaroxaban and apixaban can be used safely in people with liver cirrhosis that is not too severe. It may help doctors understand the safest way to prevent or treat blood clots in this group.
This study looks at blood clotting in patients with cirrhosis who are getting a TIPS—a tube placed in the liver to help blood flow. The study aims to understand how the procedure affects bleeding and clotting, which could help make it safer for people with liver disease.
This trial compares two tests (ROTEM and TEG) that help doctors decide which blood products to give to cirrhosis patients with active stomach or intestinal bleeding that is not from varices. The goal is to find which test works better.
This trial studies bleeding problems in people with advanced liver cirrhosis or liver cancer. It aims to improve understanding of when blood transfusions or treatments are needed.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.